Euromonitor International
- Item successfully added to cart!
  
  Your cart is empty
  
  View Cart Check Out

Country Report

Analgesics in

Analgesics in South Korea

Nov 2020

US$990

Add to cart Pay by invoice

New Report Guarantee

If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE!

Executive Summary

New Report Guarantee

If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE!

2020 IMPACT

The outbreak of COVID-19 encourages sales of analgesics, with positive results for aspirin

The outbreak of COVID-19 encouraged consumers to purchase analgesics in Q1 and Q2 of 2020, through fear of catching the virus, with many consumers concerned that the pandemic would cause supply issues. This is set to result in positive value growth for acetaminophen and ibuprofen, with adult aspirin moving from negative growth in 2019 to predicted positive growth in 2020.

Less visits to the doctor leads to a decline in Rx prescriptions of analgesics, boosting sales for OTC options

Due to the outbreak of COVID-19, consumers suffering from minor symptoms have been avoiding visiting doctors. As such, this is leading to a decline of Rx prescription analgesics, a factor which is boosting OTC sales in 2020.

The outbreak of COVID-19 leads to a strong performance for Tylenol and Advil, while domestic players focus on specific-needs to boost sales

Tylenol and Advil are both set to record positive value growth in 2020, with the outbreak of COVID-19 increasing sales. Although Tylenol is the best-selling acetaminophen, the product has a high portion of prescription users, which allows consumers to access Tylenol at a much lower price.

Files are delivered directly into your account within a few minutes of purchase.

Samples

Analgesics Market Sample Report Analgesics Market Sample Data

Overview

Why buy this report?

Gain competitive intelligence about market leaders. Track key industry trends, opportunities and threats. Inform your marketing, brand, strategy and market development, sales and supply functions.

Samples (FAQs about samples):

Delivery: Files are delivered directly into your account within a few minutes of purchase.

Overview

Discover the latest market trends and uncover sources of future market growth for the Analgesics industry in South Korea with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Analgesics industry in South Korea, our research will save you time and money while empowering you to make informed, profitable decisions.

The Analgesics in South Korea market research report includes:

Analysis of key supply-side and demand trends
Detailed segmentation of international and local products
Historic volumes and values, company and brand market shares
Five year forecasts of market trends and market growth
Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

What is the market size of Analgesics in South Korea?
What are the major brands in South Korea?
Are combination products with acetaminophen still popular?

Why buy this report?

Gain competitive intelligence about market leaders
Track key industry trends, opportunities and threats
Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our Consumer Health market research database.

Want to find out more about this report?

Request more information

Analgesics in South Korea - Category analysis

KEY DATA FINDINGS

2020 IMPACT

The outbreak of COVID-19 encourages sales of analgesics, with positive results for aspirin

Less visits to the doctor leads to a decline in Rx prescriptions of analgesics, boosting sales for OTC options

The outbreak of COVID-19 leads to a strong performance for Tylenol and Advil, while domestic players focus on specific-needs to boost sales

RECOVERY AND OPPORTUNITIES

Sales recover as value growth remains steady across the forecast period, boosted by consumers growing knowledge of OTC analgesics

Topical analgesics/anaesthetic recovers in 2021, before recording high growth across the forecast period

Slow product development will stifle growth over the forecast period, as the landscape faces maturity

CATEGORY DATA

Table 1 Sales of Analgesics by Category: Value 2015-2020
Table 2 Sales of Analgesics by Category: % Value Growth 2015-2020
Table 3 NBO Company Shares of Analgesics: % Value 2016-2020
Table 4 LBN Brand Shares of Analgesics: % Value 2017-2020
Table 5 Forecast Sales of Analgesics by Category: Value 2020-2025
Table 6 Forecast Sales of Analgesics by Category: % Value Growth 2020-2025

Consumer Health in South Korea - Industry Overview

EXECUTIVE SUMMARY

COVID-19 impact on consumer health

COVID-19 country impact

Company response

Retailing shift

What next for consumer health?

MARKET INDICATORS

Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2015-2020
Table 8 Life Expectancy at Birth 2015-2020

MARKET DATA

Table 9 Sales of Consumer Health by Category: Value 2015-2020
Table 10 Sales of Consumer Health by Category: % Value Growth 2015-2020
Table 11 NBO Company Shares of Consumer Health: % Value 2016-2020
Table 12 LBN Brand Shares of Consumer Health: % Value 2017-2020
Table 13 Distribution of Consumer Health by Format: % Value 2015-2020
Table 14 Distribution of Consumer Health by Format and Category: % Value 2020
Table 15 Forecast Sales of Consumer Health by Category: Value 2020-2025
Table 16 Forecast Sales of Consumer Health by Category: % Value Growth 2020-2025

Megatrends

Country Report

Analgesics in South Korea

New Report Guarantee

Executive Summary

New Report Guarantee

2020 IMPACT

The outbreak of COVID-19 encourages sales of analgesics, with positive results for aspirin

Less visits to the doctor leads to a decline in Rx prescriptions of analgesics, boosting sales for OTC options

The outbreak of COVID-19 leads to a strong performance for Tylenol and Advil, while domestic players focus on specific-needs to boost sales

Samples

Overview

Why buy this report?

Samples (FAQs about samples):

Want to find out more about this report?

Table of Contents

Analgesics in South Korea - Category analysis

KEY DATA FINDINGS

2020 IMPACT

The outbreak of COVID-19 encourages sales of analgesics, with positive results for aspirin

Less visits to the doctor leads to a decline in Rx prescriptions of analgesics, boosting sales for OTC options

The outbreak of COVID-19 leads to a strong performance for Tylenol and Advil, while domestic players focus on specific-needs to boost sales

RECOVERY AND OPPORTUNITIES

Sales recover as value growth remains steady across the forecast period, boosted by consumers growing knowledge of OTC analgesics

Topical analgesics/anaesthetic recovers in 2021, before recording high growth across the forecast period

Slow product development will stifle growth over the forecast period, as the landscape faces maturity

CATEGORY DATA

Consumer Health in South Korea - Industry Overview

EXECUTIVE SUMMARY

COVID-19 impact on consumer health

COVID-19 country impact

Company response

Retailing shift

What next for consumer health?

MARKET INDICATORS

MARKET DATA

APPENDIX

OTC registration and classification

Vitamins and dietary supplements registration and classification

Self-medication/self-care and preventive medicine

Switches

GLOBAL MACROECONOMIC ENVIRONMENT

GLOBAL INDUSTRY ENVIRONMENT

DISCLAIMER

DEFINITIONS

SOURCES

Why buy this report?

Want to find out more about this report?

Recently Viewed

Complete Catalogue

Country Reports

Strategy Reports

Recently Viewed

Complete Catalogue

Country Reports

Strategy Reports